Literature DB >> 12818643

Local roles of TGF-beta superfamily members in the control of ovarian follicle development.

Philip G Knight1, Claire Glister.   

Abstract

Members of the transforming growth factor-beta (TGF-beta) superfamily have wide-ranging influences on many tissue and organ systems including the ovary. Two recently discovered TGF-beta superfamily members, growth/differentiation factor-9 (GDF-9) and bone morphogenetic protein-15 (BMP-15; also designated as GDF-9B) are expressed in an oocyte-specific manner from a very early stage and play a key role in promoting follicle growth beyond the primary stage. Follicle growth to the small antral stage does not require gonadotrophins but appears to be driven by local autocrine/paracrine signals from both somatic cell types (granulosa and theca) and from the oocyte. TGF-beta superfamily members expressed by follicular cells and implicated in this phase of follicle development include TGF-beta, activin, GDF-9/9B and several BMPs. Acquisition of follicle-stimulating hormone (FSH) responsiveness is a pre-requisite for growth beyond the small antral stage and evidence indicates an autocrine role for granulosa-derived activin in promoting granulosa cell proliferation, FSH receptor expression and aromatase activity. Indeed, some of the effects of FSH on granulosa cells may be mediated by endogenous activin. At the same time, activin may act on theca cells to attenuate luteinizing hormone (LH)-dependent androgen production in small to medium-size antral follicles. Dominant follicle selection appears to depend on differential FSH sensitivity amongst a growing cohort of small antral follicles. Activin may contribute to this selection process by sensitizing those follicles with the highest "activin tone" to FSH. Production of inhibin, like oestradiol, increases in selected dominant follicles, in an FSH- and insulin-like growth factor-dependent manner and may exert a paracrine action on theca cells to upregulate LH-induced secretion of androgen, an essential requirement for further oestradiol secretion by the pre-ovulatory follicle. Like activin, BMP-4 and -7 (mostly from theca), and BMP-6 (mostly from oocyte), can enhance oestradiol and inhibin secretion by bovine granulosa cells while suppressing progesterone secretion; this suggests a functional role in delaying follicle luteinization and/or atresia. Follistatin, on the other hand, may favor luteinization and/or atresia by bio-neutralizing intrafollicular activin and BMPs. Activin receptors are expressed by the oocyte and activin may have a further intrafollicular role in the terminal stages of follicle differentiation to promote oocyte maturation and developmental competence. In a reciprocal manner, oocyte-derived GDF-9/9B may act on the surrounding cumulus granulosa cells to attenuate oestradiol output and promote progesterone and hyaluronic acid production, mucification and cumulus expansion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818643     DOI: 10.1016/s0378-4320(03)00089-7

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  60 in total

Review 1.  Fetal and early postnatal environmental exposures and reproductive health effects in the female.

Authors:  Teresa K Woodruff; Cheryl Lyn Walker
Journal:  Fertil Steril       Date:  2008-02       Impact factor: 7.329

2.  First evidence of bone morphogenetic protein 1 expression and activity in sheep ovarian follicles.

Authors:  Elizabeth Canty-Laird; Gwenn-Aël Carré; Béatrice Mandon-Pépin; Karl E Kadler; Stéphane Fabre
Journal:  Biol Reprod       Date:  2010-03-31       Impact factor: 4.285

3.  Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo.

Authors:  Qinglei Li; Stephanie A Pangas; Carolina J Jorgez; Jonathan M Graff; Michael Weinstein; Martin M Matzuk
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

4.  Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Authors:  Ermioni Prapa; Anna Vasilaki; Konstantinos Dafopoulos; Eleni Katsiani; Panagiotis Georgoulias; Christina I Messini; George Anifandis; Ioannis E Messinis
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

Review 5.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

Review 6.  Mechanisms controlling germline cyst breakdown and primordial follicle formation.

Authors:  Chao Wang; Bo Zhou; Guoliang Xia
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

7.  Polymorphism detection of promoter region of IFN-γ and IL-2 genes and their association with productive traits in Mazandaran native breeder fowls.

Authors:  Hamed Kazemi; Mojtaba Najafi; Elaheh Ghasemian; Ghodrat Rahimi-Mianji; Zarbakht Ansari Pirsaraei
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

8.  Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.

Authors:  Annie A Guedikian; Alexandria Y Lee; Tristan R Grogan; David H Abbott; Karla Largaespada; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  Fertil Steril       Date:  2018-02-07       Impact factor: 7.329

9.  Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.

Authors:  Daniel A Dumesic; Timothy G Lesnick; Jacques P Stassart; G David Ball; Ashley Wong; David H Abbott
Journal:  Fertil Steril       Date:  2009-07       Impact factor: 7.329

Review 10.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.